ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

VICKI WYSONG NP

950 N MARKET ST UNION COUNTY MEDICAL CENTER

Liberty | Indiana | 47353

(765) 458-5191

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,177Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 309

$295K Total Retail Price of All Prescriptions

Rank: 48 out of 309

304 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 304 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

24% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 4,028 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 360 199 S3 1 1
LISINOPRIL 320 215 2 2
OMEPRAZOLE 230 133 3 4
METFORMIN HCL 221 139 4 9
SIMVASTATIN 207 148 5 5
PRAVASTATIN SODIUM 184 114 6 12
FUROSEMIDE 169 93 7 7
CITALOPRAM HBR 151 66 8 16
LEVOTHYROXINE SODIUM 146 114 9 3
METOPROLOL TARTRATE 145 104 10 11
TRAMADOL HCL 138 57 11 15
GABAPENTIN 129 44 12 8
RANITIDINE HCL 102 53 13 37
AMLODIPINE BESYLATE 94 63 14 6
WARFARIN SODIUM 92 32 15 24
HYDROCHLOROTHIAZIDE 90 47 16 10
GLIMEPIRIDE 86 51 17 47
LOVASTATIN 76 56 18 41
FLUOXETINE HCL 74 39 19 36
PANTOPRAZOLE SODIUM 74 34 19 78
SERTRALINE HCL 73 55 21 19
PREDNISONE 70 56 22 43
POTASSIUM CHLORIDE 68 38 23 21
ATORVASTATIN CALCIUM 67 46 24 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 37 25 28
CRESTOR 65 23 25 26
VENTOLIN HFA 62 12 27 174
PROAIR HFA 61 20 28 29
CLOPIDOGREL 59 42 29 34
ZOLPIDEM TARTRATE 58 33 30 18
ALLOPURINOL 58 26 30 66
CARVEDILOL 56 39 32 17
DONEPEZIL HCL 55 37 33 61
NEXIUM 53 25 34 33
CYMBALTA 53 26 34 22
TRIAMTERENE-HCTZ 53 49 34 123
ADVAIR DISKUS 52 0 37 103
CYCLOBENZAPRINE HCL 51 11 R 38 31
ESTRADIOL 50 29 R 39 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.